Stocks
Grifols, S.A.GRFS
NASDAQHealthcareBiotechnology$7.81-2.01%
A major producer of plasma‑derived medicines used to treat immune deficiencies, neurological disorders, and other chronic conditions, the company operates one of the world’s largest networks of plasma collection centers. Its portfolio includes immunoglobulins, albumin, and transfusion medicine produ...
Market Cap: $6.6B52W Range: $6.19 – $11.14
Congressional Interest in Grifols, S.A. (GRFS)
2 members of Congress have disclosed 3 trades in Grifols, S.A. (GRFS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Who in Congress Is Trading GRFS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-31 | Daniel Goldman | sell | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |